17-74748976-C-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_004252.5(NHERF1):āc.130C>Gā(p.Pro44Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00015 in 1,607,066 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_004252.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NHERF1 | NM_004252.5 | c.130C>G | p.Pro44Ala | missense_variant | 1/6 | ENST00000262613.10 | NP_004243.1 | |
SLC9A3R1-AS1 | NR_187307.1 | n.806-49G>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NHERF1 | ENST00000262613.10 | c.130C>G | p.Pro44Ala | missense_variant | 1/6 | 1 | NM_004252.5 | ENSP00000262613.5 | ||
NHERF1 | ENST00000583369.5 | c.130C>G | p.Pro44Ala | missense_variant | 1/3 | 3 | ENSP00000464321.1 |
Frequencies
GnomAD3 genomes AF: 0.000776 AC: 118AN: 152108Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000262 AC: 60AN: 228628Hom.: 1 AF XY: 0.000215 AC XY: 27AN XY: 125682
GnomAD4 exome AF: 0.0000845 AC: 123AN: 1454840Hom.: 1 Cov.: 32 AF XY: 0.0000788 AC XY: 57AN XY: 723440
GnomAD4 genome AF: 0.000775 AC: 118AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.000699 AC XY: 52AN XY: 74424
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 05, 2024 | The c.130C>G (p.P44A) alteration is located in exon 1 (coding exon 1) of the SLC9A3R1 gene. This alteration results from a C to G substitution at nucleotide position 130, causing the proline (P) at amino acid position 44 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 28, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at